Research study Program year 2025 Source: CMS Open Payments

A Randomized Phase 3 Double-Blinded Study Comparing the Efficacy and S

Research payments

$1,327,408

504 payments

Through program year 2025, $1,327,408 in research payments was reported against A Randomized Phase 3 Double-Blinded Study Comparing the Efficacy and S, across 504 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$64,660	48
2024	Research	$173,463	94
2023	Research	$744,250	252
2022	Research	$335,535	108
2021	Research	$9,500	2

Breakdown

Who paid Research payments · program years 2021–2025

GlaxoSmithKline, LLC. $1,327,408 504 payments

Who received the money Research payments · program years 2021–2025

US Oncology ResearchLLC Organisation paid for research $454,281 130 payments
New Mexico Cancer Care Alliance Organisation paid for research $78,063 22 payments
The Regents Of The University Of Organisation paid for research $72,128 22 payments
Regents Of The University Of Colorado Organisation paid for research $68,919 34 payments
US Oncology Research INC Organisation paid for research $59,775 27 payments
City of Hope National Medical Center Organisation paid for research $46,894 14 payments
Trustees Of Columbia University In The City Of New York Organisation paid for research $46,718 15 payments
Yale University Organisation paid for research $38,896 17 payments
Providence Health System Southern California Organisation paid for research $38,582 23 payments
Institute for Cancer Research Organisation paid for research $34,928 11 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.